About

Maria Furlan is a leading urologic surgeon and researcher whose work has fundamentally advanced the field of nephron-sparing surgery for kidney cancer. Her research focuses on optimizing surgical techniques—specifically robotic and minimally invasive partial nephrectomy—to maximize both oncologic control and renal function preservation. She is best known for her pivotal role in the CLOCK randomized controlled trial (NCT02287987), which rigorously compared on-clamp versus off-clamp robotic partial nephrectomy. Her landmark 2021 paper from this trial (103 citations) demonstrated the functional benefits of the off-clamp approach, while her 2019 safety analysis (55 citations) confirmed its perioperative safety. Furlan has also been instrumental in the RECORd and RECORD2 multicenter projects, producing highly cited work on predictive factors for complications (52 citations) and comparing transperitoneal versus retroperitoneal approaches (51 citations). Her 2015 comparative study of open, laparoscopic, and robotic partial nephrectomy for T1b tumors (132 citations) remains a cornerstone reference. With over 500 cumulative citations across her top ten papers, Furlan’s evidence-based contributions are shaping global surgical standards for kidney cancer treatment.

Research Focus

Key Achievements

13
H-Index
20
Papers
674
Total Citations
34
Avg Citations/Paper
🏆 Most Cited Paper
Partial Nephrectomy in Clinical T1b Renal Tumors: Multicenter Comparative Study of Open, Laparoscopic and Robot-assisted Approach (the RECORd Project)
132 citations · 2015
📈 Most Prolific Year: 2021 (4 Papers)
🤝 Key Collaborators: 162
🏛 Institutions: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Ospedale San Donato, University of Brescia

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago